Indoco Remedies receives EIR from USFDA for Goa Plant-I

The PAI was conducted for two drug product applications (ANDAs) filed from this facility

Zydus receives USFDA’s approvals for Pimavanserin Capsules, 34 mg and Pimavanserin Tablets,10 mg

Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis

Tritan used for safer medical infusion therapy

This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device

Pharmatech Associates adds Dr. Praveen Tyle to Board of Trustees

Bayer, Sun Pharma sign marketing and distribution agreement for second brand of Finerenone in India

Bayer has granted the non-exclusive rights to Sun Pharma to market and distribute a second brand of Finerenone under the brand name Lyvelsa

CuraTeQ Biologics receives recommendation for grant of marketing authorization of 'biosimilar trastuzumab'

Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer

Lupin receives USFDA’s approval or Propranolol Hydrochloride Extended-Release Capsules USP

Ayush gets big boost in the North East

India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid

Health Minister Mandaviya inaugurates NIPER in Guwahati

Lays foundation stone of NIPER Hyderabad and NIPER Raebareli

USFDA approves Merck’s Keytruda plus chemoradiotherapy with FIGO 2014 stage III-IVA cervical cancer

Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients